Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 20/02/19 → 31/12/19 |
A Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Efficacy Study of Staccato Alprazolam (STAP-001) in Subjects with Epilepsy with a Predictable Seizure Pattern. ENGAGE study.
- O'Brien, Terence (Primary Chief Investigator (PCI))
- Kwan, Patrick (Chief Investigator (CI))
- Mullen, Saul Alator (Chief Investigator (CI))
Project: Research